Schramm Vern Lee 4
4 · AzurRx BioPharma, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Schramm Vern Lee
Director
Transactions
- Award
Common Stock
2019-12-31$1.04/sh+7,500$7,800→ 67,500 total
Footnotes (1)
- [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019.